Stock Price
54.27
Daily Change
-1.88 -3.35%
Monthly
19.59%
Yearly
-58.61%
Q3 Forecast
54.42

Novo Nordisk reported DKK38.94B in Cash and Equivalent for its fiscal quarter ending in March of 2025.


Cash And Equivalent Change Date
ANI Pharmaceuticals USD 217.8M 67.99M Jun/2025
Aurora Cannabis CAD 140.16M 31.45M Jun/2025
Bausch Health Companies USD 1.73B 593M Jun/2025
Bristol-Myers Squibb USD 12.6B 1.72B Jun/2025
Canopy Growth CAD 126.2M 109.89M Jun/2025
Corcept Therapeutics USD 102.74M 12.93M Jun/2025
Drreddys Laboratories INR 9B 7.91B Jun/2025
Eli Lilly USD 3.38B 282.6M Jun/2025
GlaxoSmithKline GBP 3.6B 865M Jun/2025
Merck USD 8.01B 622M Jun/2025
Novartis USD 6.66B 410M Jun/2025
Novo Nordisk DKK 38.94B 18.08B Mar/2025
Novo Nordisk A/S 18.44B 5.78B Jun/2025
Pacira USD 300.48M 16.87M Jun/2025
Perrigo USD 454.2M 44.3M Jun/2025
Prestige Brands USD 139.5M 41.62M Jun/2025
Sanofi EUR 15.36B 7.37B Jun/2025
Supernus Pharmaceuticals USD 144.71M 28.86M Jun/2025
Zoetis USD 1.44B 286M Jun/2025